National MS Society: Early Stem Cell Trial Shows Safety in People With Secondary Progressive MS
November 28, 2023
November 28, 2023
NEW YORK, Nov. 28 (TNSres) -- The National Multiple Sclerosis Society issued the following news:
An international team tested a novel strategy to transplant nerve stem cells directly into the brains of 15 people with secondary progressive multiple sclerosis. No serious adverse events occurred, and participants' physical and cognitive functions remained stable for one year afterward. Further study is necessary to determine the potential of this strategy for stopping MS progression an . . .
An international team tested a novel strategy to transplant nerve stem cells directly into the brains of 15 people with secondary progressive multiple sclerosis. No serious adverse events occurred, and participants' physical and cognitive functions remained stable for one year afterward. Further study is necessary to determine the potential of this strategy for stopping MS progression an . . .